Listed

XBiotech Inc.

XBITNasdaqCIK 1626878HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2023
Operating income−$6.1m, Q2 FY2026
Net income−$6.7m, Q2 FY2026
XBiotech Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-03-15, accession 0001171843-24-001382. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$m0.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure0.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2024-03-15, accession 0001171843-24-001382. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$m0.0Gross profit, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure0.0Gross profit, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-15, accession 0001171843-24-001382. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m7.5Research and development, Q3 FY2023, three months to 2023-09-30$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure7.8Research and development, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2024, three months to 2024-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure13.0Research and development, Q2 FY2024, three months to 2024-06-30$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure7.1Research and development, Q3 FY2024, three months to 2024-09-30$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure7.8Research and development, Q4 FY2024, three months to 2024-12-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure11.6Research and development, Q1 FY2025, three months to 2025-03-31$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure5.3Research and development, Q2 FY2025, three months to 2025-06-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure5.1Research and development, Q3 FY2025, three months to 2025-09-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure25.4Research and development, Q4 FY2025, three months to 2025-12-31$25.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure5.2Research and development, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure5.3Research and development, Q2 FY2026, three months to 2026-06-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Operating income$m(8.5)Operating income, Q3 FY2023, three months to 2023-09-30−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure(8.6)Operating income, Q4 FY2023, three months to 2023-12-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-15, accession 0001171843-24-001382.Report this figure(10.9)Operating income, Q1 FY2024, three months to 2024-03-31−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure(15.0)Operating income, Q2 FY2024, three months to 2024-06-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure(7.9)Operating income, Q3 FY2024, three months to 2024-09-30−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure(8.7)Operating income, Q4 FY2024, three months to 2024-12-31−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(13.6)Operating income, Q1 FY2025, three months to 2025-03-31−$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(6.3)Operating income, Q2 FY2025, three months to 2025-06-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure(6.0)Operating income, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure(29.8)Operating income, Q4 FY2025, three months to 2025-12-31−$29.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(6.3)Operating income, Q1 FY2026, three months to 2026-03-31−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(6.1)Operating income, Q2 FY2026, three months to 2026-06-30−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Income tax$m0.3Income tax, Q3 FY2023, three months to 2023-09-30$308.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure(0.1)Income tax, Q4 FY2023, three months to 2023-12-31−$99.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$25.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure(0.0)Income tax, Q2 FY2024, three months to 2024-06-30−$25.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$41.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$102.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$76.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$46.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Net income$m(7.4)Net income, Q3 FY2023, three months to 2023-09-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure(4.6)Net income, Q4 FY2023, three months to 2023-12-31−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-15, accession 0001171843-24-001382.Report this figure(10.0)Net income, Q1 FY2024, three months to 2024-03-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure(13.0)Net income, Q2 FY2024, three months to 2024-06-30−$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure(5.0)Net income, Q3 FY2024, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure(10.5)Net income, Q4 FY2024, three months to 2024-12-31−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Net income, Q1 FY2025, three months to 2025-03-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(1.8)Net income, Q2 FY2025, three months to 2025-06-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure(6.0)Net income, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure(26.9)Net income, Q4 FY2025, three months to 2025-12-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Net income, Q1 FY2026, three months to 2026-03-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(6.7)Net income, Q2 FY2026, three months to 2026-06-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.24)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure(0.15)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-15, accession 0001171843-24-001382.Report this figure(0.33)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure(0.43)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure(0.16)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figurenot reported(0.36)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(0.06)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure(0.20)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figurenot reported(0.18)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(0.22)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure

Balance sheet

Cash and equivalents$109.5m, Q2 FY2026
Shareholders' equity$128.5m, Q2 FY2026
XBiotech Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m202Cash and equivalents, Q3 FY2023, at 2023-09-30$202.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure200Cash and equivalents, FY2023, at 2023-12-31$200.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001171843-25-001527.Report this figure201Cash and equivalents, Q1 FY2024, at 2024-03-31$201.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001171843-24-002746.Report this figure189Cash and equivalents, Q2 FY2024, at 2024-06-30$188.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001171843-24-004689.Report this figure183Cash and equivalents, Q3 FY2024, at 2024-09-30$183.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure173Cash and equivalents, FY2024, at 2024-12-31$172.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure156Cash and equivalents, Q1 FY2025, at 2025-03-31$155.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure153Cash and equivalents, Q2 FY2025, at 2025-06-30$152.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure147Cash and equivalents, Q3 FY2025, at 2025-09-30$147.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure126Cash and equivalents, FY2025, at 2025-12-31$125.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure115Cash and equivalents, Q1 FY2026, at 2026-03-31$115.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure110Cash and equivalents, Q2 FY2026, at 2026-06-30$109.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Current assets$m204Current assets, Q3 FY2023, at 2023-09-30$204.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure202Current assets, FY2023, at 2023-12-31$201.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001171843-25-001527.Report this figure203Current assets, Q1 FY2024, at 2024-03-31$203.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001171843-24-002746.Report this figure191Current assets, Q2 FY2024, at 2024-06-30$190.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001171843-24-004689.Report this figure185Current assets, Q3 FY2024, at 2024-09-30$185.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure175Current assets, FY2024, at 2024-12-31$174.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure158Current assets, Q1 FY2025, at 2025-03-31$157.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure155Current assets, Q2 FY2025, at 2025-06-30$154.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure149Current assets, Q3 FY2025, at 2025-09-30$149.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure127Current assets, FY2025, at 2025-12-31$127.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure117Current assets, Q1 FY2026, at 2026-03-31$117.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure111Current assets, Q2 FY2026, at 2026-06-30$111.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Total assets$m230Total assets, Q3 FY2023, at 2023-09-30$229.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure227Total assets, FY2023, at 2023-12-31$226.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001171843-25-001527.Report this figure228Total assets, Q1 FY2024, at 2024-03-31$227.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001171843-24-002746.Report this figure216Total assets, Q2 FY2024, at 2024-06-30$215.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001171843-24-004689.Report this figure210Total assets, Q3 FY2024, at 2024-09-30$209.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure199Total assets, FY2024, at 2024-12-31$199.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure182Total assets, Q1 FY2025, at 2025-03-31$181.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure179Total assets, Q2 FY2025, at 2025-06-30$178.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure172Total assets, Q3 FY2025, at 2025-09-30$172.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure150Total assets, FY2025, at 2025-12-31$150.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure140Total assets, Q1 FY2026, at 2026-03-31$139.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure134Total assets, Q2 FY2026, at 2026-06-30$133.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Current liabilities$m5.3Current liabilities, Q3 FY2023, at 2023-09-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure6.1Current liabilities, FY2023, at 2023-12-31$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001171843-25-001527.Report this figure16.9Current liabilities, Q1 FY2024, at 2024-03-31$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001171843-24-002746.Report this figure17.1Current liabilities, Q2 FY2024, at 2024-06-30$17.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001171843-24-004689.Report this figure16.0Current liabilities, Q3 FY2024, at 2024-09-30$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure15.1Current liabilities, FY2024, at 2024-12-31$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure5.4Current liabilities, Q1 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure3.9Current liabilities, Q2 FY2025, at 2025-06-30$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure3.6Current liabilities, Q3 FY2025, at 2025-09-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure7.9Current liabilities, FY2025, at 2025-12-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure3.0Current liabilities, Q1 FY2026, at 2026-03-31$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure3.4Current liabilities, Q2 FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Total liabilities$m6.9Total liabilities, Q3 FY2023, at 2023-09-30$6.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001171843-23-006944.Report this figure7.8Total liabilities, FY2023, at 2023-12-31$7.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001171843-25-001527.Report this figure18.6Total liabilities, Q1 FY2024, at 2024-03-31$18.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001171843-24-002746.Report this figure18.9Total liabilities, Q2 FY2024, at 2024-06-30$18.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001171843-24-004689.Report this figure17.7Total liabilities, Q3 FY2024, at 2024-09-30$17.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure16.8Total liabilities, FY2024, at 2024-12-31$16.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure7.2Total liabilities, Q1 FY2025, at 2025-03-31$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure5.6Total liabilities, Q2 FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure5.3Total liabilities, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure9.7Total liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure4.8Total liabilities, Q1 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure5.2Total liabilities, Q2 FY2026, at 2026-06-30$5.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure
Shareholders' equity$m223Shareholders' equity, Q3 FY2023, at 2023-09-30$222.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001171843-24-006336.Report this figure219Shareholders' equity, FY2023, at 2023-12-31$218.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-13, accession 0001171843-26-001561.Report this figure209Shareholders' equity, Q1 FY2024, at 2024-03-31$209.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001171843-25-005368.Report this figure197Shareholders' equity, Q2 FY2024, at 2024-06-30$196.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure192Shareholders' equity, Q3 FY2024, at 2024-09-30$192.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure182Shareholders' equity, FY2024, at 2024-12-31$182.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure175Shareholders' equity, Q1 FY2025, at 2025-03-31$174.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure173Shareholders' equity, Q2 FY2025, at 2025-06-30$173.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure167Shareholders' equity, Q3 FY2025, at 2025-09-30$167.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001171843-25-007233.Report this figure140Shareholders' equity, FY2025, at 2025-12-31$140.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure135Shareholders' equity, Q1 FY2026, at 2026-03-31$135.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure128Shareholders' equity, Q2 FY2026, at 2026-06-30$128.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001171843-26-005492.Report this figure

Cash flow

Operating cash flow−$4.5m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Share repurchases$0, Q4 FY2024
XBiotech Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(1.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001171843-24-006336. Derived: 9-month figure less the 6-month figure.Report this figure(3.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figure(7.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure(11.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001171843-25-005368. Derived: 6-month figure less the 3-month figure.Report this figure(5.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001171843-25-007233. Derived: 9-month figure less the 6-month figure.Report this figure(6.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(6.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001171843-26-005492. Derived: 6-month figure less the 3-month figure.Report this figure(4.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001171843-25-007233. Derived: 9-month figure less the 6-month figure.Report this figure(23.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure(4.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001171843-26-005492. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$33.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001171843-24-006336. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$255.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001171843-25-003178.Report this figure0.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$627.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001171843-25-005368. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$338.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001171843-25-007233. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$84.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$94.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001171843-26-005492. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$110.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001171843-25-007233. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001171843-26-001561. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001171843-26-003419.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001171843-26-005492. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001171843-24-006336. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001171843-24-006336. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-18, accession 0001171843-25-001527. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.